Skip to content
vibegron

Structure via PubChem · Public domain (PubChem)

EntityQ27283524· pop 7· linked from 597 articles

Also known as Gemtesa

Vibegron, sold under the brand name Gemtesa, is a medication for the treatment of overactive bladder. Vibegron is a selective beta-3 adrenergic receptor agonist.

Chemical data

Formula
C26H28N4O3
Molecular weight
444.5 g/mol
IUPAC name
(6S)-N-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]phenyl]-4-oxo-7,8-dihydro-6H-pyrrolo[1,2-a]pyrimidine-6-carboxamide
SMILES
C1C[C@@H](N[C@@H]1CC2=CC=C(C=C2)NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)[C@@H](C5=CC=CC=C5)O
InChIKey
DJXRIQMCROIRCZ-XOEOCAAJSA-N
XLogP
1.8
Polar surface area
94 Ų
H-bond donors
3
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
Admin. routes
oral
Indications
overactive bladder, hypertension, irritable bowel syndrome, Urinary incontinence

via ChEMBL · EBI

Wikidata facts

Mass
444.216
Show 3 more facts
canonical SMILES
C1CC(NC1CC2=CC=C(C=C2)NC(=O)C3CCC4=NC=CC(=O)N34)C(C5=CC=CC=C5)O
chemical formula
C₂₆H₂₈N₄O₃
isomeric SMILES
C1C[C@@H](N[C@@H]1CC2=CC=C(C=C2)NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)[C@@H](C5=CC=CC=C5)O
Sources (2)

via Wikidata · CC0

~8 min read

Encyclopedic overview

15 sections
Contents
  • Efficacy
  • Medical uses
  • Safety
  • Adverse effects
  • Interactions
  • Pharmacology
  • Mechanism of action
  • Pharmacokinetics
  • History
  • Society and culture
  • Legal status
  • Names
  • Veterinary uses
  • References
  • External links

Vibegron, sold under the brand name Gemtesa, is a medication for the treatment of overactive bladder. Vibegron is a selective beta-3 adrenergic receptor agonist.

The most common side effects include headache, urinary tract infection, common cold, diarrhea, nausea, and upper respiratory tract infection.

Excerpted from Wikipedia’s “vibegron” article, available under the CC BY-SA 4.0 licence.

Available in 7 languages

via Wikidata sitelinks · CC0